Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...
Fintel on MSN5d
Wells Fargo Downgrades Bausch + Lomb (BLCO)
Fintel reports that on March 28, 2025, Wells Fargo downgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Overweight to ...
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, ...
Bausch + Lomb downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24.Light Up your Portfolio ...
Investing5d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Investing.com -- Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to ...